Business, energy, technology, markets and global industry news from Business News Today

Ebola virus disease

PharmaDeviceNews Ebola virus disease
Representative image: Laboratory research on macrophage-targeted therapies highlights 101 Therapeutics’ push for independent review of 101-PGC-005 in Bundibugyo Ebola disease.
Pharma & Biotech

Can 101 Therapeutics’ macrophage-targeting approach change the race for a Bundibugyo Ebola treatment?

101 Therapeutics has released new data on 101-PGC-005 for Bundibugyo Ebola disease. Discover what it could mean for outbreak response and drug development.

Read More
Pharma & Biotech

Could Hyundai Bioscience’s XAFTY become a crisis-response antiviral for Ebola and hantavirus?

Ebola urgency is rising, but broad-spectrum antivirals still face a proof gap. Hyundai Bioscience’s XAFTY now enters that debate.

Read More